Save your place

Sign in to WhoBought

Please try again later.

Vertex Pharmaceuticals Incorporated (VRTX) institutional ownership

Latest close $477.10 Jul 31, 2026
Market cap$126.8B 52-week range SectorHealthcare
Funds holding · Q1 2026
1,517
reported VRTX position changes
Top owners · Q2 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Net sold $1.4B
822 buyers · 695 sellers

Vertex Pharmaceuticals Incorporated (VRTX) price and institutional activity

Dates

Q1 2026

$6.0B bought by 822 investors
Capital Research Global Investors$1.8BJPMorgan Chase & Co$464M +820 more
$7.4B sold by 695 investors
Norges-$1.5BVictory Capital Management Inc-$685M +693 more
Bought Sold Totals per quarter; hover a bar for the names.

Vertex Pharmaceuticals Incorporated (VRTX) institutional activity · 1,517

Investor Type Est. change Change Δ Own Date
Capital Research Global Investors · Added +$1.8B
Change +3.8M Δ Own +22.0% Date Q1 2026
Capital Research Global Investors Added· Q1 2026 +$1.8B +3.8M +22.0% Q1 2026
Norges · Exited −$1.5B
Change −3.2M Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −$1.5B −3.2M −100.0% Q1 2026
Victory Capital Management Inc · Reduced −$685M
Change −1.5M Date Q1 2026
Victory Capital Management Inc Reduced· Q1 2026 −$685M −1.5M Q1 2026
JPMorgan Chase & Co · Added +$464M
Change +994K Date Q1 2026
JPMorgan Chase & Co Added· Q1 2026 +$464M +994K Q1 2026
Winslow Capital Management, LLC · Exited −$414M
Change −888K Δ Own −100.0% Date Q1 2026
Winslow Capital Management, LLC Exited· Q1 2026 −$414M −888K −100.0% Q1 2026
Goldman Sachs Group Inc · Added +$310M
Change +664K Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +$310M +664K Q1 2026
Wellington Management Group LLP · Reduced −$284M
Change −609K Δ Own −15.9% Date Q1 2026
Wellington Management Group LLP Reduced· Q1 2026 −$284M −609K −15.9% Q1 2026
Alliancebernstein L.P. · Reduced −$273M
Change −586K Date Q1 2026
Alliancebernstein L.P. Reduced· Q1 2026 −$273M −586K Q1 2026
T. Rowe Price Associates · Reduced −$242M
Change −519K Date Q1 2026
T. Rowe Price Associates Reduced· Q1 2026 −$242M −519K Q1 2026
Jennison Associates LLC · Reduced −$238M
Change −509K Date Q1 2026
Jennison Associates LLC Reduced· Q1 2026 −$238M −509K Q1 2026
Dz Bank AG Deutsche Zentral Genossenschafts Bank, Frankfurt AM Main · Reduced −$205M
Change −439K Date Q1 2026
Dz Bank AG Deutsche Zentral Genossenschafts Bank, Frankfurt AM Main Reduced· Q1 2026 −$205M −439K Q1 2026
Nordea Investment Management AB · Reduced −$196M
Change −420K Date Q1 2026
Nordea Investment Management AB Reduced· Q1 2026 −$196M −420K Q1 2026
Pictet Asset Management Holding SA · Reduced −$194M
Change −415K Date Q1 2026
Pictet Asset Management Holding SA Reduced· Q1 2026 −$194M −415K Q1 2026
Invesco Ltd. · Added +$191M
Change +408K Δ Own +19.0% Date Q1 2026
Invesco Ltd. Added· Q1 2026 +$191M +408K +19.0% Q1 2026
Capital International Investors · Added +$183M
Change +392K Date Q1 2026
Capital International Investors Added· Q1 2026 +$183M +392K Q1 2026
Data through Q1 2026 · filed Jun 11, 2026
15 of 1517

Famous investor activity in Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals Incorporated (VRTX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Tatsis Ourania · Officer Grant (A) 8K
Owned 54K ΔOwn +18.2% Trade date Jul 21, 2026 Filed date Jul 23, 2026
Tatsis Ourania Officer Grant (A) 8K 54K +18.2% Jul 21, 2026 Jul 23, 2026
Sachdev Amit · Officer Grant (A) 8K
Owned 67K ΔOwn +14.2% Trade date Jul 21, 2026 Filed date Jul 23, 2026
Sachdev Amit Officer Grant (A) 8K 67K +14.2% Jul 21, 2026 Jul 23, 2026
Sachs Bruce I. · Director Grant (A) $47K
Price $475.28 Qty 100 Owned 16K Trade date Jul 15, 2026 Filed date Jul 17, 2026
Sachs Bruce I. Director Grant (A) $475.28 100 $47K 16K Jul 15, 2026 Jul 17, 2026
Garber Alan M. · Director Grant (A) $15K
Price $475.28 Qty 32 Owned 65 Trade date Jul 15, 2026 Filed date Jul 17, 2026
Garber Alan M. Director Grant (A) $475.28 32 $15K 65 Jul 15, 2026 Jul 17, 2026
Tatsis Ourania · Officer Sell −$787K
Price $524.99 Qty −2K Owned 45K ΔOwn −3.2% Trade date Jul 2, 2026 Filed date Jul 7, 2026
Tatsis Ourania Officer Sell $524.99 −2K −$787K 45K −3.2% Jul 2, 2026 Jul 7, 2026
McKechnie Duncan · Officer Sell −$800K
Price $519.00 Qty −2K Owned 11K ΔOwn −12.3% Trade date Jul 2, 2026 Filed date Jul 7, 2026
McKechnie Duncan Officer Sell $519.00 −2K −$800K 11K −12.3% Jul 2, 2026 Jul 7, 2026
Liu Joy · Officer Sell −$416K
Price $502.71 Qty −828 Owned 19K ΔOwn −4.1% Trade date Jul 1, 2026 Filed date Jul 6, 2026
Liu Joy Officer Sell $502.71 −828 −$416K 19K −4.1% Jul 1, 2026 Jul 6, 2026
Bozic Carmen · Officer Sell −$288K
Price $482.50 Qty −596 Owned 15K ΔOwn −3.7% Trade date Jun 26, 2026 Filed date Jun 30, 2026
Bozic Carmen Officer Sell $482.50 −596 −$288K 15K −3.7% Jun 26, 2026 Jun 30, 2026
Bozic Carmen · Officer Sell −$471K
Price $462.17 Qty −1K Owned 16K ΔOwn −6.0% Trade date Jun 18, 2026 Filed date Jun 23, 2026
Bozic Carmen Officer Sell $462.17 −1K −$471K 16K −6.0% Jun 18, 2026 Jun 23, 2026
Bozic Carmen · Officer Sell −$1.8M
Price $450.00 Qty −4K Owned 17K Trade date Jun 15, 2026 Filed date Jun 17, 2026
Bozic Carmen Officer Sell $450.00 −4K −$1.8M 17K Jun 15, 2026 Jun 17, 2026
Bozic Carmen · Officer Sell −$785K
Price $450.00 Qty −2K Owned 21K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Bozic Carmen Officer Sell $450.00 −2K −$785K 21K Jun 5, 2026 Jun 9, 2026
Liu Joy · Officer Sell −$364K
Price $439.91 Qty −828 Owned 20K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Liu Joy Officer Sell $439.91 −828 −$364K 20K Jun 1, 2026 Jun 3, 2026
Bozic Carmen · Officer Sell −$888K
Price $450.00 Qty −2K Owned 23K Trade date May 29, 2026 Filed date Jun 2, 2026
Bozic Carmen Officer Sell $450.00 −2K −$888K 23K May 29, 2026 Jun 2, 2026
Bunnage Mark E. · Officer Sell −$15K
Price $453.45 Qty −33 Owned 7K Trade date May 15, 2026 Filed date May 19, 2026
Bunnage Mark E. Officer Sell $453.45 −33 −$15K 7K May 15, 2026 May 19, 2026
Bozic Carmen · Officer Sell −$614K
Price $453.45 Qty −1K Owned 25K Trade date May 15, 2026 Filed date May 19, 2026
Bozic Carmen Officer Sell $453.45 −1K −$614K 25K May 15, 2026 May 19, 2026
15 of 145
15 of 145 Sign in to continue to older insider transactions.

Vertex Pharmaceuticals Incorporated (VRTX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Capital World Investors 25.7M
% of shares outstanding 10.1% Filing date May 14, 2026
Capital World Investors 25.7M 10.1% May 14, 2026
Vanguard Group Inc 22.3M
% of shares outstanding 8.7% Filing date Feb 13, 2024
Vanguard Group Inc 22.3M 8.7% Feb 13, 2024
BlackRock Inc. 21.9M
% of shares outstanding 8.5% Filing date Jan 25, 2024
BlackRock Inc. 21.9M 8.5% Jan 25, 2024
Capital Research Global Investors 21.1M
% of shares outstanding 8.3% Filing date May 14, 2026
Capital Research Global Investors 21.1M 8.3% May 14, 2026
Vanguard Capital Management 19.0M
% of shares outstanding 7.5% Filing date Apr 30, 2026
Vanguard Capital Management 19.0M 7.5% Apr 30, 2026
FMR LLC 13.0M
% of shares outstanding 5.0% Filing date Feb 9, 2024
FMR LLC 13.0M 5.0% Feb 9, 2024
T. Rowe Price Associates 5.4M
% of shares outstanding 2.1% Filing date Feb 14, 2022
T. Rowe Price Associates 5.4M 2.1% Feb 14, 2022
7 of 7

Vertex Pharmaceuticals Incorporated (VRTX) ownership FAQ

Who owns VRTX?

1,517 reporting institutions disclosed VRTX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.